Trial Profile
One Year of Statin Intervention in Dyslipidemic Obese Teenagers, a Randomized Control Trial (RCT) Pilot Study [Intervention précoce Sur Les Indices d'athérogénèse Des Adolescents à Risque]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Jan 2013
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Dyslipidaemias
- Focus Pharmacodynamics; Therapeutic Use
- 17 Jan 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01768481).
- 25 Jan 2011 New trial record